HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shruti Khanduri Selected Research

Ayush 64

6/2022AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India.
1/2022AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study.
1/2022Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review.
1/2022Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'.
4/2020AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shruti Khanduri Research Topics

Disease

5COVID-19
06/2022 - 04/2020
2Human Influenza (Influenza)
01/2022 - 01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Cough
01/2022
1Fever (Fevers)
01/2022
1Nasal Obstruction
10/2021
1Anosmia
10/2021
1Headache (Headaches)
10/2021
1Essential Hypertension
07/2021

Drug/Important Bio-Agent (IBA)

5Ayush 64IBA
06/2022 - 04/2020
2Pharmaceutical PreparationsIBA
01/2022 - 07/2020
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022
11- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA
07/2021
1Interleukin-6 (Interleukin 6)IBA
04/2020

Therapy/Procedure

1Therapeutics
10/2021
1Traditional Medicine (Folk Remedies)
04/2021